Back to today’s briefing

Story perspectives

Revolutionary Drug Approved for Advanced Breast Cancer Treatment

4/11/2025

50 5

Summary

Story summary

The NHS has greenlit capivasertib, a groundbreaking drug for advanced hormone receptor-positive HER2-negative breast cancer, offering hope to 3,000 women each year. Taken twice daily, it not only slows cancer progression but also enhances quality of life. Experts urge swift genetic testing to ensure eligible patients can access this vital treatment, heralding a new era in breast cancer care in the UK.

1 of 1

Story summary

The NHS has greenlit capivasertib, a groundbreaking drug for advanced hormone receptor-positive HER2-negative breast cancer, offering hope to 3,000 women each year. Taken twice daily, it not only slows cancer progression but also enhances quality of life. Experts urge swift genetic testing to ensure eligible patients can access this vital treatment, heralding a new era in breast cancer care in the UK.